focus -WSS

focus

author：leisure time 2025-10-01 04:11:59 - browse：763

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Orchard's therapy for neuron disease in children wins FDA approval

hotspot

WSS

Creating egg and sperm cells from stem cells raises ethical issues

Mark Cuban is blaming the wrong people for high drug costs

Methadone treatment changes are coming. Do they go far enough?

App could help diagnose ear infections more accurately — and at home

Methadone treatment changes are coming. Do they go far enough?

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

hotspot

focus

explore

State Dept. review finds Biden bears some blame for Afghanistan failures

Surge in Apellis stock fueled by confidence in safety of its eye drug

Medical records are filled with copy

What to know about the judge who will handle the Trump case

Medicare details structure of new drug price negotiation program

Methadone treatment changes are coming. Do they go far enough?

Hepatitis C has a cure — but many Americans still lack access to it

UnitedHealth increases loan offers after Change Healthcare outage

Peter Hotez and the public health issue of online harassment

Dozens dead from Maui wildfires: What we know about the victims

leisure time

Virtual Event: March of the Biosimilars

Indictment alleges Trump's ex

App could help diagnose ear infections more accurately — and at home

Creating egg and sperm cells from stem cells raises ethical issues

Patients, digital health players weigh in on FTC's data privacy plan

Methadone treatment changes are coming. Do they go far enough?

Wikipedia

hotspot

focus

knowledge